China Universal Asset Management »

Entrada Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $64k 6.2k 10.28
2025-09-30 $39k 6.7k 5.80
2025-06-30 $51k 7.6k 6.72
2025-03-31 $68k 7.5k 9.04
2024-12-31 $137k 7.9k 17.29

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics